Skip to main content
News_

Uncovering the mystery of migraine

14 October 2015
New study reveals more about what's happening in the brain

It's a disease that has baffled health professionals for years, but our researchers have taken a significant step forward in understanding migraine.

MRI brain scan indicating area of the brain where GABA is measured

A new study, published in NMR in Biomedicine, reveals higher levels of the chemical gamma-aminobutyric acid in the brain of migraine sufferers, supporting the theory that migraines are linked to a chemical imbalance in the brain.

"The finding paves the way for the discovery of new, effective treatments for migraines," said lead researcher Maria Aguila, PhD candidate in the Faculty of Health Sciences.

"For such a debilitating condition, very little is known about migraine so this is a big step forward and could lead to better diagnosis and treatment of the disease in the future," she said.

Gamma-aminobutyric acid or GABA as it is commonly known, is the most abundant inhibitory brain chemical and has long been suspected to play a role in migraines due to its ability to influence pain. This study is the first to accurately measure GABA levels in the living brain.

"We still don't know what causes migraine, how it starts and ends, or why the triggers appear to differ from one person to the next, but this discovery means that we can now be much more specific with our research going forward," said Ms Aguila.

"For example, GABA could be used to help us identify migraine sufferers and track responses to drug trials, and measuring GABA levels over a period of time could well reveal what’s causing attacks.”

The study compared the levels of GABA in twenty chronic migraine sufferers to an age and gender matched control group who did not experience any form of regular headaches. Brain scans were conducted when the participants were not having a migraine.

The measurement of GABA levels in the brain was made possible by a novel spectroscopy technique associated with MRI developed by researchers at the University of Sydney Brain and Mind Centre.

Associate Professor in Neuroimaging, Jim Lagopoulos said the ability to directly measure these chemicals in the brain would not have been possible several years ago.

“These advances not only allow us to study fundamental changes in brain chemistry that are associated with migraine, but they also open a whole new world with respect to monitoring a patient's response to treatment and compliance," he said.

The researchers were unable to tell if the increase in GABA is related to a recent migraine attack or signalling a new one as the scanning process is currently too complex to carry out during a migraine attack.

The study design was conceived by Professor Kathryn Refshauge and executed by researchers from the University of Sydney’s Faculty of Health Sciences and Brain and Mind Centre, Neuroscience Research Australia, University of the Philippines and University of New South Wales.

Related articles

23 June 2016

Australia 20 years after gun reform: no mass shootings, declining firearm deaths

Since major gun law reform 20 years ago, Australia has seen no mass shootings and an accelerating decline in intentional firearm deaths, the Journal of the American Medical Association reports today.

23 June 2016

New insights into the causes of sudden cardiac death in the young revealed

Sudden cardiac death claims the lives of 2-3 young Australians every week. 

28 June 2016

Are itchier insect bites more likely to make us sick?

New research suggests the worse our reactions to mosquito bites are, the more likely it is we’ll get sick, says Dr Cameron Webb.

15 June 2016

How can we make sense of the Orlando shooting?

As the world mourns the tragic loss of 50 lives, how can we answer the questions around homophobia and mental health raised by the Orlando shooting? Our researchers appeared on ABC’s The Drum to discuss the complex debate. 

13 December 2016

Confidence boost linked to weight loss in smartphone trial

Confidence is key when motivating young people to change their diet and exercise habits, new research from the University of Sydney shows.

13 December 2016

Sydney alum off to Stanford as Monash scholar

University of Sydney alumnus Dr Martin Seneviratne has been named the 2017 Roden Cutler NSW John Monash Scholar. The award will see Dr Seneviratne head to Stanford University to continue his ground-breaking work into clinical informatics.

14 December 2016

Brain structure best explains our dwindling tolerance of risk

Nature findings will improve understanding of decision-making, as global demographics shift toward an aged population. 

14 December 2016

Exotic mosquitoes a clear and present danger for Australians

Fears of outbreaks of Zika and dengue due to Australian travellers visiting affected countries this summer.

08 December 2016

Minister Ley launches Psychology clinics in Brain and Mind Centre

Federal Health and Aged Care Minister Sussan Ley today launched the one-stop-shop psychology, psychiatry and neuroscience clinics, touring the new facilities leading the way in multidisciplinary brain and mind care.

12 December 2016

Child mummy offers revised history of smallpox

A child mummy from the 17th century, found in a crypt underneath a Lithuanian church, was discovered to harbour the oldest known sample of the variola virus that causes smallpox.